Perrigo Absorbs Plant Remediation Sales Hit, But PBM Progresses In Q1

Continuing remediation at a facility that received an FDA warning letter took a bite out of first-quarter sales for Perrigo, but the private labeler sees continued upside in branded competitor recalls and infant formula growth in the rest of fiscal 2011.